CCR2 and metabolic dysfunction-associated steatohepatitis: In patients with NASH accompanied by fibrosis and cirrhosis, there was a notable increase in the number of pro-inflammatory macrophages expressing CCR2 in the portal areas, providing further evidence for the involvement of monocyte-derived macrophages in fibrosis development (79).